Mesfin Tegenu, MS, RPh

CEO and Chairman at RxParadigm

Speaker

Mesfin Tegenu is a nationally recognized thought leader in Pharmacy Benefit Management (PBM), who over a 25-year career, has negotiated several billion dollars in rebates with major drug manufacturers. An early pioneer of PBM, Mesfin Tegenu had previously built one of the country’s leading PBM organizations, transforming it from near start-up to an industry leader.

From his beginning as a clinical pharmacist, Mesfin Tegenu’s main focus has always been on developing innovative approaches that improve patient outcomes while reducing total cost of care. This vision often placed him at odds as the industry became less transparent and less patient centric.

His frustration led him to found RxParadigm, Inc. a new entrant into the market to facilitate the paradigm shift in the PBM marketplace, which aims to disrupt the industry by employing a never-before-available level of transparency into drug pricing and reimbursement. RxParadigm is the first pharmaceutical group purchasing entity/organization that returns 100% of drug rebates directly to its family of member PBMs and payers who can deploy those savings to improve their competitive standings, create outcome-based service offerings, and save patients and insurers money while delivering real value to the marketplace.

A regular speaker, who is frequently cited by leading trade journals for his perspectives on drug access, pricing, and management, Mesfin Tegenu immigrated from Ethiopia before earning a master’s degree from St. John’s University in Queens, New York. Tegenu holds a bachelor’s degree in pharmacy from Addis Ababa University in Addis Ababa, Ethiopia.